[96a5a0]: / output / allTrials / identified / NCT06142760_identified.json

Download this file

445 lines (445 with data), 17.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
{
"info": {
"nct_id": "NCT06142760",
"official_title": "Daily AI-based Treatment Adaptation Under Weekly Offline MR-guidance in Chemoradiotherapy for Cervical Cancer 1 AIM-C1",
"inclusion_criteria": "* biopsy-proven cervical cancer including squamous-cell carcinoma, adenocarcinoma or adeno-squamous cell carcinoma\n* FIGO stage IB, IIA, IIB, IIIA, IIIB, IIIC1\n* indication and eligibility for definitive chemoradiotherapy including brachytherapy discussed in an interdisciplinary tumor board\n* Karnofsky performance score ≥ 70%\n* 18-80 years of age\n* Capacity of the patient to consent to participation in the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* FIGO stage IIIC2 and IV\n* Paraaortic lymphatic node metastases\n* small cell neuroendocrine cancer, melanoma and other rare cancers of the cervix\n* previous radiotherapy of the pelvic region\n* previous total or partial hysterectomy\n* neoadjuvant chemotherapy\n* contraindications against performing contrast-enhanced MRI scans (pacemakers, other implants making MRI impossible, allergy to gadolinium (GD)-based contrast agent)\n* claustrophobia\n* pregnant or lactating women\n* other primary malignancies within 5 years before except carcinoma in situ of the cervix and basal cell carcinoma of the skin\n* patient is enrolled in another study, that could influence the outcome of the presented study",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* biopsy-proven cervical cancer including squamous-cell carcinoma, adenocarcinoma or adeno-squamous cell carcinoma",
"criterions": [
{
"exact_snippets": "biopsy-proven cervical cancer",
"criterion": "cervical cancer",
"requirements": [
{
"requirement_type": "diagnosis method",
"expected_value": "biopsy-proven"
}
]
},
{
"exact_snippets": "squamous-cell carcinoma",
"criterion": "cervical cancer subtype",
"requirements": [
{
"requirement_type": "subtype",
"expected_value": "squamous-cell carcinoma"
}
]
},
{
"exact_snippets": "adenocarcinoma",
"criterion": "cervical cancer subtype",
"requirements": [
{
"requirement_type": "subtype",
"expected_value": "adenocarcinoma"
}
]
},
{
"exact_snippets": "adeno-squamous cell carcinoma",
"criterion": "cervical cancer subtype",
"requirements": [
{
"requirement_type": "subtype",
"expected_value": "adeno-squamous cell carcinoma"
}
]
}
]
},
{
"line": "* FIGO stage IB, IIA, IIB, IIIA, IIIB, IIIC1",
"criterions": [
{
"exact_snippets": "FIGO stage IB, IIA, IIB, IIIA, IIIB, IIIC1",
"criterion": "FIGO stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"IB",
"IIA",
"IIB",
"IIIA",
"IIIB",
"IIIC1"
]
}
]
}
]
},
{
"line": "* indication and eligibility for definitive chemoradiotherapy including brachytherapy discussed in an interdisciplinary tumor board",
"criterions": [
{
"exact_snippets": "indication and eligibility for definitive chemoradiotherapy including brachytherapy",
"criterion": "indication and eligibility for definitive chemoradiotherapy including brachytherapy",
"requirements": [
{
"requirement_type": "discussion",
"expected_value": "interdisciplinary tumor board"
}
]
}
]
},
{
"line": "* Karnofsky performance score ≥ 70%",
"criterions": [
{
"exact_snippets": "Karnofsky performance score ≥ 70%",
"criterion": "Karnofsky performance score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "%"
}
}
]
}
]
},
{
"line": "* 18-80 years of age",
"criterions": [
{
"exact_snippets": "18-80 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 80,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Capacity of the patient to consent to participation in the study",
"criterions": [
{
"exact_snippets": "Capacity of the patient to consent",
"criterion": "capacity to consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* FIGO stage IIIC2 and IV",
"criterions": [
{
"exact_snippets": "FIGO stage IIIC2",
"criterion": "FIGO stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IIIC2"
}
]
},
{
"exact_snippets": "FIGO stage ... IV",
"criterion": "FIGO stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IV"
}
]
}
]
},
{
"line": "* Paraaortic lymphatic node metastases",
"criterions": [
{
"exact_snippets": "Paraaortic lymphatic node metastases",
"criterion": "paraaortic lymphatic node metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* small cell neuroendocrine cancer, melanoma and other rare cancers of the cervix",
"criterions": [
{
"exact_snippets": "small cell neuroendocrine cancer",
"criterion": "small cell neuroendocrine cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "melanoma",
"criterion": "melanoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "other rare cancers of the cervix",
"criterion": "rare cancers of the cervix",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* previous radiotherapy of the pelvic region",
"criterions": [
{
"exact_snippets": "previous radiotherapy of the pelvic region",
"criterion": "radiotherapy",
"requirements": [
{
"requirement_type": "location",
"expected_value": "pelvic region"
},
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* previous total or partial hysterectomy",
"criterions": [
{
"exact_snippets": "previous total or partial hysterectomy",
"criterion": "hysterectomy",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"total",
"partial"
]
},
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* neoadjuvant chemotherapy",
"criterions": [
{
"exact_snippets": "neoadjuvant chemotherapy",
"criterion": "neoadjuvant chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* contraindications against performing contrast-enhanced MRI scans (pacemakers, other implants making MRI impossible, allergy to gadolinium (GD)-based contrast agent)",
"criterions": [
{
"exact_snippets": "contraindications against performing contrast-enhanced MRI scans (pacemakers, other implants making MRI impossible",
"criterion": "contraindications for MRI",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "allergy to gadolinium (GD)-based contrast agent",
"criterion": "allergy to gadolinium-based contrast agent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* claustrophobia",
"criterions": [
{
"exact_snippets": "claustrophobia",
"criterion": "claustrophobia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* pregnant or lactating women",
"criterions": [
{
"exact_snippets": "pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "lactating women",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* other primary malignancies within 5 years before except carcinoma in situ of the cervix and basal cell carcinoma of the skin",
"criterions": [
{
"exact_snippets": "other primary malignancies within 5 years before",
"criterion": "other primary malignancies",
"requirements": [
{
"requirement_type": "time since diagnosis",
"expected_value": {
"operator": "<",
"value": 5,
"unit": "years"
}
}
]
},
{
"exact_snippets": "except carcinoma in situ of the cervix",
"criterion": "carcinoma in situ of the cervix",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": true
}
]
},
{
"exact_snippets": "except ... basal cell carcinoma of the skin",
"criterion": "basal cell carcinoma of the skin",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": true
}
]
}
]
},
{
"line": "* patient is enrolled in another study, that could influence the outcome of the presented study",
"criterions": [
{
"exact_snippets": "patient is enrolled in another study",
"criterion": "enrollment in another study",
"requirements": [
{
"requirement_type": "influence on outcome",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}